Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC. Cancer Discov. 2023 07 07; 13(7):1556-1571.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
DNA Helicases
Humans
Kelch-Like ECH-Associated Protein 1
Lung Neoplasms
Mutation
NF-E2-Related Factor 2
Nuclear Proteins
Phosphatidylinositol 3-Kinases
Transcription Factors
authors with profiles
Christine Bestvina
Marina Chiara Garassino